San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor during the weight loss drug current market in February right after revealing promising details from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified to be a weekly injection and in Ma